NEW YORK (GenomeWeb) – Human Longevity has struck a deal with health insurance company Discovery to offer exome, whole-genome and cancer genome sequencing services for Discovery's customers in South Africa and the UK.

Through the agreement, Discovery's clients will be able to access exome sequencing and analysis for $250. The genomic services will be offered through Discovery's Vitality program, a behavioral wellness opportunity that enables behavior-linked insurance pricing. Discovery also partners with other global insurers through its Vitality program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.